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PELP1 (proline, glutamic acid, and leucine rich protein 1) is an 
estrogen receptor co-activator protein that is a potential 
biomarker for breast cancer. It normally localizes in the nucleus of 
cells, but is found to localize in the cytoplasm in 40% samples from 
women at high-risk for developing breast cancer.  
For pre-cancerous lesions, such as ductal carcinoma in situ (DCIS) 
to become invasive breast cancer, cells must acquire genetic and 
epigenetic changes that allow them to invade through the 
basement membrane. 
I hypothesize that PELP1 cytoplasmic signaling participates in 
breast cancer initiation by promoting epithelial cell migration and 
stem-cell phenotype, making it a good potential biomarker for 
breast cancer.
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Figure 1: PELP1-cyto cells formed significantly more 
tumorspheres than PELP1-wt and control cells in both 1o and 2o 
tumorsphere assays. In the 2o tumorsphere assay, PELP1-cyto 
cells formed larger tumorspheres than other cells.
Figure 2: PELP1-cyto cells treated with EGF had higher migration 
levels, as shown by percent closure, than PELP1-wt or control 
cells. Untreated PELP1-wt cells showed significantly lower 
migration levels than PELP1-cyto and control cells.
The tumorsphere assay demonstrated the ability of PELP1-cyto 
cells  to form tumorspheres, suggesting that cytoplasmic 
localization of PELP1 promotes a stem-cell phenotype. Tumor cells 
with stem cell phenotypes and typically also have a migratory 
phenotype.  
The scratch assay, while not significant, was trending towards 
showing that PELP1-cyto cells have greater migratory ability than 
PELP1-wt cells. This would suggest that cytoplasmic localization of 
PELP1 may allow for increased migration of pre-cancerous cells.
Increased migratory ability and returning to a stem cell phenotype 
are traits seen in cells progressing toward cancer.
Future Directions
Could PELP1 a biomarker for breast cancer? More studies need to 
be done to find out.
•Transwell assays can be performed to further test migration and 
invasion.
•Gene expression analysis can be performed with qPCR. 
•Cells could be tested for tumorigenicity in vivo a mouse model 
using intraductal injection into the breast duct to mimic DCIS.
PELP1 as a biomarker could be used clinically to determine which 
women will likely develop breast cancer, and could be used to 
make treatment decisions. 
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